HSN-002066

N/A

Report date: 2024/11/20 16:40:02
NME

Base Information

Drug NameHSN-002066
Drug Alias NameHSN002066HSN-002066
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTCDD-inducible poly [ADP-ribose] polymerase inhibitors
TargetsTCDD-inducible poly [ADP-ribose] polymerase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChongqing Pharscin Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChongqing Pharscin Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A